Cargando…
An EU-wide approach to HTA: An irrelevant development or an opportunity not to be missed?
An EU-wide cooperation on HTA has been proposed recently by the European Commission, focusing on relative effectiveness assessment (REA) for pharmaceuticals and medical devices. This cooperation is operationalised through a proposal for a regulation. While a good step in the right direction, this HT...
Autores principales: | Kanavos, Panos, Angelis, Aris, Drummond, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6438931/ https://www.ncbi.nlm.nih.gov/pubmed/30868380 http://dx.doi.org/10.1007/s10198-019-01037-2 |
Ejemplares similares
-
Applying Multiple Criteria Decision Analysis (MCDA) in the context of HTA: an experimental case study on metastatic colorectal cancer
por: Angelis, Aris, et al.
Publicado: (2015) -
The development of HTA collaboration at European level and the challenge of the EU regulation
por: Ruether, A, et al.
Publicado: (2022) -
Acquiring Pharmaceutical Industry Assets in the UK: 1 + 1 = 1?
por: Kanavos, Panos, et al.
Publicado: (2014) -
Value-Based Assessment of New Medical Technologies: Towards a Robust Methodological Framework for the Application of Multiple Criteria Decision Analysis in the Context of Health Technology Assessment
por: Angelis, Aris, et al.
Publicado: (2016) -
Using Multiple Criteria Decision Analysis (MCDA) to make coverage decisions: a methodological framework
por: Kanavos, Panos, et al.
Publicado: (2015)